Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NERV Minerva Neurosciences

盘后交易 05-06 18:26:14 EDT

2.34

-0.03

-1.27%

盘后2.43

+0.09+3.71%

18:12 EDT

最高2.41	最低2.32	成交量9,314
今开2.41	昨收2.37	日振幅3.80%
总市值1,636万	流通市值1,272万	总股本699.34万
成交额2.21万	换手率0.17%	流通股本543.55万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NERV","market":"US","secType":"STK","nameCN":"Minerva Neurosciences","latestPrice":2.34,"timestamp":1715025600000,"preClose":2.37,"halted":0,"volume":9314,"hourTrading":{"tag":"盘后","latestPrice":2.4267,"preClose":2.34,"latestTime":"18:12 EDT","volume":55,"amount":132.000099,"timestamp":1715033544228},"delay":0,"floatShares":5435531,"shares":6993406,"eps":-4.474189,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.03,"latestTime":"05-06 18:26:14 EDT","open":2.41,"high":2.41,"low":2.32,"amount":22057.996925000003,"amplitude":0.037975,"askPrice":2.62,"askSize":7,"bidPrice":2.33,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.474189,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715040000000},"adr":0,"listingDate":1404187200000,"adjPreClose":2.37,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.4267,"preClose":2.34,"latestTime":"18:12 EDT","volume":55,"amount":132.000099,"timestamp":1715033544228},"volumeRatio":0.647768},"requestUrl":"/m/hq/s/NERV","defaultTab":"news","newsList":[{"id":"2422292371","title":"Minerva Neurosciences, Inc盘中异动 股价大跌5.06%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422292371","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422292371?lang=zh_cn&edition=full","pubTime":"2024-03-28 03:53","pubTimestamp":1711569221,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日03时53分，Minerva Neurosciences, Inc股票出现异动，股价快速下挫5.06%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Ibio, Inc.、Nutriband Inc C/Wts 、Moolec Science Sa C/Wts 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为4740.29%、1355.70%、90.49%，振幅较大的相关个股有Ibio, Inc.、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为150.43%、91.94%、78.00%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032803534187e7c5d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032803534187e7c5d7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422626943","title":"Minerva Neurosciences, Inc盘中异动 下午盘快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422626943","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422626943?lang=zh_cn&edition=full","pubTime":"2024-03-27 03:29","pubTimestamp":1711481374,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日03时29分，Minerva Neurosciences, Inc股票出现波动，股价大幅下跌5.08%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.53%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327032934861e14ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327032934861e14ee&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421654029","title":"Minerva Neurosciences, Inc盘中异动 急速下跌5.19%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421654029","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421654029?lang=zh_cn&edition=full","pubTime":"2024-03-22 00:13","pubTimestamp":1711037606,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日00时13分，Minerva Neurosciences, Inc股票出现波动，股价大幅下挫5.19%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.96%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322001326861e029f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322001326861e029f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419568473","title":"Minerva Neurosciences, Inc盘中异动 大幅拉升5.42%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419568473","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419568473?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:34","pubTimestamp":1710336892,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时34分，Minerva Neurosciences, Inc股票出现异动，股价大幅上涨5.42%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Nucana Plc、Estrella Immunopharma Inc C/Wts 29/09/2028、Kintara Therapeutics, Inc.涨幅较大，Kintara Therapeutics, Inc.、Nucana Plc、Revelation Biosciences, Inc.较为活跃，换手率分别为101.00%、41.23%、19.81%，振幅较大的相关个股有Nucana Plc、Kintara Therapeutics, Inc.、Cybin Inc.，振幅分别为18.67%、17.94%、17.27%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313213452791a1a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313213452791a1a5c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418935011","title":"Minerva Neurosciences, Inc盘中异动 早盘股价大跌6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418935011","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418935011?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:35","pubTimestamp":1710164110,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时35分，Minerva Neurosciences, Inc股票出现波动，股价大幅下跌6.07%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.60%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。其产品组合和潜在适应症包括：罗鲁哌酮，用于治疗精神分裂症患者阴性症状； Seltorexant，用于治疗失眠症和重度抑郁症； MIN-117，用于治疗 MDD； MIN-301，用于治疗帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112135117919597c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112135117919597c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418415064","title":"Minerva Neurosciences, Inc盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418415064","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418415064?lang=zh_cn&edition=full","pubTime":"2024-03-09 00:43","pubTimestamp":1709916215,"startTime":"0","endTime":"0","summary":"北京时间2024年03月09日00时43分，Minerva Neurosciences, Inc股票出现波动，股价快速拉升5.08%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.24%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。其产品组合和潜在适应症包括：罗鲁哌酮，用于治疗精神分裂症患者阴性症状； Seltorexant，用于治疗失眠症和重度抑郁症； MIN-117，用于治疗 MDD； MIN-301，用于治疗帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090043367918ab62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090043367918ab62&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416128916","title":"Minerva Neurosciences, Inc盘中异动 快速下挫5.21%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416128916","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416128916?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:12","pubTimestamp":1709565121,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时12分，Minerva Neurosciences, Inc股票出现异动，股价大幅下跌5.21%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.01%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。其产品组合和潜在适应症包括：罗鲁哌酮，用于治疗精神分裂症患者阴性症状； Seltorexant，用于治疗失眠症和重度抑郁症； MIN-117，用于治疗 MDD； MIN-301，用于治疗帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042312017a49530c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042312017a49530c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416641369","title":"Minerva Neurosciences, Inc盘中异动 早盘股价大涨5.24%报2.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416641369","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416641369?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:40","pubTimestamp":1709304011,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时40分，Minerva Neurosciences, Inc股票出现波动，股价大幅上涨5.24%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Biovie Inc.、Adial Pharmaceuticals, Inc、Ys Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Biovie Inc.较为活跃，换手率分别为1522.19%、199.23%、82.14%，振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Biovie Inc.、Adial Pharmaceuticals, Inc，振幅分别为71.25%、54.84%、40.69%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122401179165e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122401179165e4a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415404125","title":"Minerva Neurosciences, Inc盘中异动 股价大涨7.07%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415404125","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415404125?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:33","pubTimestamp":1709217199,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时33分，Minerva Neurosciences, Inc股票出现异动，股价快速拉升7.07%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.25%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922331987e74e28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922331987e74e28&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415320565","title":"Minerva Neurosciences Inc盘中异动 早盘快速拉升8.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415320565","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415320565?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:31","pubTimestamp":1709130668,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时31分，Minerva Neurosciences Inc股票出现异动，股价快速上涨8.21%。Minerva Neurosciences Inc股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Vtv Therapeutics Inc、Applied Therapeutics Inc涨幅较大，Adial Pharmaceuticals Inc、Silo Pharma Inc、Zyversa Therapeutics Inc较为活跃，换手率分别为71.20%、47.64%、41.41%，振幅较大的相关个股有Adial Pharmaceuticals Inc、Zyversa Therapeutics Inc、Kiniksa Pharmaceuticals Ltd，振幅分别为20.61%、11.01%、10.77%。Minerva Neurosciences Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822310987ccca26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822310987ccca26&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414887794","title":"BUZZ-Minerva Neurosciences 因 FDA 拒绝批准精神分裂症药物而下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2414887794","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414887794?lang=zh_cn&edition=full","pubTime":"2024-02-27 21:55","pubTimestamp":1709042108,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    2月27日 - ** Minerva Neurosciences   股价在盘前交易中暴跌约64.7%，至2.40美元 ** 该公司称 (link)，美国FDA拒绝批准其药物用于调节精神分裂症患者的行为变化，这种变化可能导致社交退缩和缺乏动力。** NERV表示，FDA认为该药物（罗鲁派利酮）的中后期研究数据不足以证明其有效性。 ** 卫生监管机构的这一决定标志着 Minerva 面临的又一障碍，此前该机构曾拒绝审查 Minerva 于 2022 年提出的该药物首次上市申请。 ** 截至上一交易日收盘，股价累计上涨10.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414838481","title":"Minerva Neurosciences Inc盘中异动 股价大涨9.61%报7.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414838481","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414838481?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:36","pubTimestamp":1708958160,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时36分，Minerva Neurosciences Inc股票出现异动，股价快速上涨9.61%。Minerva Neurosciences Inc股票所在的生物技术行业中，整体涨幅为0.16%。Minerva Neurosciences Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022622360087e73255&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022622360087e73255&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413076484","title":"Minerva Neurosciences Inc股价上涨11.86% 市值涨672.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413076484","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413076484?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:32","pubTimestamp":1708698732,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时32分，Minerva Neurosciences Inc股票出现波动，股价急速上涨11.86%。Minerva Neurosciences Inc股票所在的生物技术行业中，整体涨幅为0.50%。Minerva Neurosciences Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322321281ae78f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322321281ae78f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413147642","title":"Minerva Neurosciences Inc盘中异动 早盘大幅拉升5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413147642","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413147642?lang=zh_cn&edition=full","pubTime":"2024-02-22 22:34","pubTimestamp":1708612484,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日22时34分，Minerva Neurosciences Inc股票出现波动，股价快速拉升5.68%。Minerva Neurosciences Inc股票所在的生物技术行业中，整体涨幅为0.84%。Minerva Neurosciences Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402222234457a45baf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402222234457a45baf5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412510587","title":"Minerva Neurosciences Inc盘中异动 早盘急速上涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412510587","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412510587?lang=zh_cn&edition=full","pubTime":"2024-02-20 22:39","pubTimestamp":1708439947,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日22时39分，Minerva Neurosciences Inc股票出现异动，股价急速拉升5.78%。Minerva Neurosciences Inc股票所在的生物技术行业中，整体涨幅为0.60%。Minerva Neurosciences Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240220223907861d679a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240220223907861d679a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412716695","title":"Minerva Neurosciences Inc盘中异动 快速下跌5.21%报8.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2412716695","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412716695?lang=zh_cn&edition=full","pubTime":"2024-02-17 01:39","pubTimestamp":1708105165,"startTime":"0","endTime":"0","summary":"北京时间2024年02月17日01时39分，Minerva Neurosciences Inc股票出现波动，股价快速跳水5.21%。Minerva Neurosciences Inc股票所在的生物技术行业中，整体涨幅为0.40%。Minerva Neurosciences Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170139257a440522&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170139257a440522&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411581540","title":"Minerva Neurosciences Inc盘中异动 急速拉升7.62%报10.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411581540","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411581540?lang=zh_cn&edition=full","pubTime":"2024-02-15 01:08","pubTimestamp":1707930520,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日01时08分，Minerva Neurosciences Inc股票出现异动，股价大幅拉升7.62%。Minerva Neurosciences Inc股票所在的生物技术行业中，整体涨幅为0.40%。Minerva Neurosciences Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215010840861d5415&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215010840861d5415&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411287148","title":"Minerva Neurosciences Inc盘中异动 临近收盘股价大跌5.81%报9.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411287148","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411287148?lang=zh_cn&edition=full","pubTime":"2024-02-13 04:53","pubTimestamp":1707771223,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日04时53分，Minerva Neurosciences Inc股票出现异动，股价大幅跳水5.81%。Minerva Neurosciences Inc股票所在的生物技术行业中，整体跌幅为0.47%。Minerva Neurosciences Inc公司简介：Minerva Neurosciences Inc 是一家临床阶段的生物制药公司，主要专注于治疗中枢神经系统疾病患者的候选产品组合的开发和商业化。其产品组合和潜在适应症包括：罗鲁哌酮，用于治疗精神分裂症患者阴性症状； Seltorexant，用于治疗失眠症和重度抑郁症； MIN-117，用于治疗 MDD； MIN-301，用于治疗帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402130453447a43573a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402130453447a43573a&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minervaneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.0273},{"period":"1month","weight":-0.0669},{"period":"3month","weight":-0.7489},{"period":"6month","weight":-0.5699},{"period":"1year","weight":-0.4859},{"period":"ytd","weight":-0.6146}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Minerva Neurosciences, Inc.在Cyrenaic制药公司的名义下根据特拉华州法律于2007年4月23日成立。2013年11月，它合并了Sonkei制药有限公司以及合并后的公司更名为密涅瓦神经科学有限公司。作为合并，或Sonkei合并的结果，该公司有权在全球范围内开发，销售和进口MIN- 101和MIN -117，根据与三菱田边制药公司许可协议的权利，不包括亚洲大部分地区。公司通过收购Mind-NRG SA（或Mind-NRG）的股份，在2014年2月进一步扩大其产品候选组合，它具有独家开发和商业化MIN- 301，或 Mind-NRG 收购的权利。公司是一家临床阶段的生物制药公司，专注于发展和商业化候选产品的组合来治疗病人中枢神经系统（或 CNS）疾病。公司的主导候选产品是MIN- 101——它正在开发用于治疗精神分裂症的治疗化合物，和MIN -117 ——公司正在开发用于治疗重性抑郁障碍的痛苦治疗化合物（或MDD ）。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.093479},{"month":2,"riseRate":0.2,"avgChangeRate":-0.109643},{"month":3,"riseRate":0.3,"avgChangeRate":-0.000761},{"month":4,"riseRate":0.5,"avgChangeRate":0.05689},{"month":5,"riseRate":0.6,"avgChangeRate":0.161527},{"month":6,"riseRate":0.555556,"avgChangeRate":0.044317},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.045427},{"month":8,"riseRate":0.5,"avgChangeRate":0.347447},{"month":9,"riseRate":0.4,"avgChangeRate":0.00871},{"month":10,"riseRate":0.2,"avgChangeRate":-0.236602},{"month":11,"riseRate":0.6,"avgChangeRate":0.100298},{"month":12,"riseRate":0.4,"avgChangeRate":-0.089821}],"exchange":"NASDAQ","name":"Minerva Neurosciences","nameEN":"Minerva Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Minerva Neurosciences,NERV,Minerva Neurosciences股票,Minerva Neurosciences股票老虎,Minerva Neurosciences股票老虎国际,Minerva Neurosciences行情,Minerva Neurosciences股票行情,Minerva Neurosciences股价,Minerva Neurosciences股市,Minerva Neurosciences股票价格,Minerva Neurosciences股票交易,Minerva Neurosciences股票购买,Minerva Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}